Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9638829 | 0.75 | TSHR (0.46) | TSHR | |
| SCHEMBL9638454 | 0.75 | TSHR (0.41) | TSHR | |
| SCHEMBL7627471 | 0.70 | TSHR (0.46) | TSHR | |
| SCHEMBL339727 | 0.67 | TSHR (0.39) | TSHR | |
| SCHEMBL6557963 | 0.67 | TSHR (0.48) | TSHR | |
| Adamantane SCHEMBL2284749 | 0.64 | ALDH1A1 (0.60) | — | |
| SCHEMBL4791985 | 0.62 | TSHR (0.43) | TSHR | |
| Adamantane SCHEMBL28705266 | 0.61 | GRIN2D (0.45) | TSHR | |
| SCHEMBL1072862 | 0.60 | TSHR (0.41) | TSHR | |
| SCHEMBL2488748 | 0.60 | TSHR (0.41) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7192606-B2 | Drugs for treating viral infections | VASSIL STEFANOV GEORGIEV (US) | 2007-03-20 | — | — | US | disclosed |
| US-7192606-B2 | Drugs for treating viral infections | VASSIL STEFANOV GEORGIEV (US) | 2007-03-20 | — | — | US | disclosed |
| US-7192606-B2 | Drugs for treating viral infections | VASSIL STEFANOV GEORGIEV (US) | 2007-03-20 | — | — | US | disclosed |
| US-20050192358-A1 | Drugs for treating viral infections | GEORGIEV VASSIL S (US) | 2005-09-01 | — | — | US | disclosed |
| US-6596771-B2 | Imidodisulfamide derivatives | SCHERING CORPORATION | 2003-07-22 | — | — | US | disclosed |
| WO-2003004461-A1 | DRUGS FOR TREATING VIRAL INFECTIONS | SCHERING CORPORATION (US) | 2003-01-16 | — | — | WO | disclosed |
| US-20020193443-A1 | Drugs for treating viral infections | SCHERING CORPORATION | 2002-12-19 | — | — | US | disclosed |
| US-20020132851-A1 | DRUGS FOR TREATING VIRAL INFECTIONS | GEORGIEV VASSIL STEFANOV (US) | 2002-09-19 | — | — | US | disclosed |
| US-6433016-B1 | CARBOCYCLIC IMIDODISULFAMIDE DERIVATIVE VIRICIDES FOR ORTHOPOXVIRUSES | GEORGIEV VASSIL STEFANOV (US) | 2002-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192358-A1 | Drugs for treating viral infections | ITPA, MAVS, PPIP5K2 | TSHR 3964/4885 |
| US-20020132851-A1 | DRUGS FOR TREATING VIRAL INFECTIONS | EIF2AK2, MAVS, SORD | TSHR 4261/4885 |
| US-20020193443-A1 | Drugs for treating viral infections | EIF2AK2, MAVS, DDX5 | TSHR 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.